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Background:  Many patients admitted for acute myocardial infarction (AMI, ST and Non-ST Elevation MI)) have concomitant renal insufficiency. We 
report on the quality of inpatient care of patients in whom these conditions coexist from the American Heart Association - Get With the Guidelines 
Coronary Artery Disease Program.
Methods:   We examined inpatient performance measures for AMI care by renal function based on estimated glomerular filtration rate (GFR 
- MDRD Equation). Renal function was 
categorized as normal (GFR > 90), mild (90 
> GFR > 60), moderate (60 > GFR > 30), 
severe (30 > GFR > 15), and renal failure 
(GFR < 15 or dialysis). A total of 21,721 
patients from 291 sites from July 2001 to 
Jan 2010 were studied. Patients lacking data 
required to calculate GFR or no AMI were 
excluded. Multivariable regression analysis 
after adjusting for patient and hospital 
characteristics was performed to compare 
quality of care and mortality. Generalized 
estimating equations were used to adjust for 
within-hospital clustering.
Results: Patients with worsening renal 
function had higher mortality and were less 
likely to receive guideline-based therapy 
(Table 1). In-hospital mortality was 1.5%, 
2.7%, 8.9%, 16.0%, and 13.4% for normal, 
mild, moderate, severe, and renal failure, 
respectively (P<0.0001).
Conclusions:  Despite being at substantially 
higher risk for mortality, patients with renal 
dysfunction were significantly less likely to 
receive guideline-recommended therapy for 
AMI in the absence of contraindications. 
Adjusted Odds Ratio
Outcome
Rates of Attainment of Quality Measure for Renal 
Function Category, n/N (%) Eligible Patients Only
Variable N OR
Lower (95% CI 
for OR)
Upper (95% CI 
for OR)
Door to Balloon within 90 min
Overall 1847/2643 (69.88%) 2643
Normal 471/619 (76.09%)
Mild 901/1240 (72.66%) Mild vs. Normal 1240 0.88 0.70 1.10
Moderate 400/600 (66.67%) Moderate vs. Normal 600 0.80 0.60 1.06
Severe 27/48 (56.25%) Severe vs. Normal 48 0.68 0.33 1.39
Failure 48/136 (35.29%)
Kidney failure vs. 
Normal
136 0.25 0.16 0.39
Discharge Clopidogrel for AMI and patients with 
percutaneous intervention
Overall 12152/16111 (75.43%) 16111
Normal 2962/3505 (83.21%)
Mild 4926/6042 (81.53%) Mild vs. Normal 6042 0.99 0.86 1.14
Moderate 2697/3728 (72.34%) Moderate vs. Normal 3728 0.82 0.71 0.94
Severe 456/757 (60.24%) Severe vs. Normal 757 0.56 0.45 0.70
Failure 1381/2349 (58.79%)
Kidney failure vs. 
Normal
2349 0.47 0.39 0.58
Discharge ACE or ARB for Left ventricular systolic 
dysfunction (LVSD - LV ejection fraction < 40%)
Overall 2693/3209 (83.92%) 3452
Normal 474/482 (90.80%)
Mild 1024/1192 (85.91%) Mild vs. Normal 1229 0.79 0.47 1.33
Moderate 690/840 (82.14%) Moderate vs. Normal 875 0.82 0.50 1.35
Severe 95/128 (74.22%) Severe vs. Normal 140 0.38 0.19 0.77
Failure 410/527 (77.80%)
Kidney failure vs. 
Normal
672 0.16 0.09 0.28
Discharge Aspirin
Overall 16438/16890 (97.32%) 16890
Normal 3330/3387 (98.32%)
Mild 6293/6406 (98.24%) Mild vs. Normal 6406 0.93 0.73 1.19
Moderate 3847/3963 (97.07%) Moderate vs. Normal 3963 0.83 0.63 1.09
Severe 749/779 (96.15%) Severe vs. Normal 779 0.72 0.45 1.18
Failure 2219/2355 (94.23%)
Kidney failure vs. 
Normal
2355 0.46 0.32 0.67
Discharge Beta Blockers
Overall 16241/16712 (97.18%) 16712
Normal 3203/3270 (97.95%)
Mild 6119/6242 (98.03%) Mild vs. Normal 6242 1.12 0.86 1.46
Moderate 3855/3976 (96.96%) Moderate vs. Normal 3976 0.88 0.66 1.18
Severe 791/815 (97.06%) Severe vs. Normal 815 0.90 0.54 1.50
Failure 2273/2409 (94.35%)
Kidney failure vs. 
Normal
2409 0.57 0.40 0.80
Lipid lowering drugs for LDL>100
Overall 4039/4352 (92.81%) 4352
Normal 1139/1201 (94.84%)
Mild 1959/2056 (95.28%) Mild vs. Normal 2056 1.30 0.96 1.76
Moderate 706/784 (90.05%) Moderate vs. Normal 784 0.92 0.61 1.38
Severe 81/106 (76.42%) Severe vs. Normal 106 0.51 0.32 0.81
Failure 154/205 (75.12%)
Kidney failure vs. 
Normal
205 0.41 0.23 0.72
In-hospital mortality
Overall 1321/18874 (6.51%) 20195
Normal 56/3662 (1.53%)
Mild 194/7145 (2.71%) Mild vs. Normal 7145 1.45 1.03 2.05
Moderate 450/5006 (8.95%) Moderate vs. Normal 5006 3.36 2.31 4.89
Severe 184/1141 (16.04%) Severe vs. Normal 1141 5.43 3.70 7.95
Failure 437/3241 (13.38%)
Kidney failure vs. 
Normal
3241 6.35 4.48 9.01
